世界の遅発性ジスキネジア（TD）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Tardive Dyskinesia (TD) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5550 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、遅発性ジスキネジア（TD）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（バルベナジン、アマンタジン、テトラベナジン、クロナゼパム、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・遅発性ジスキネジア（TD）治療の市場動向 ・企業の競争状況、市場シェア ・遅発性ジスキネジア（TD）治療の種類別市場規模（バルベナジン、アマンタジン、テトラベナジン、クロナゼパム、その他） ・遅発性ジスキネジア（TD）治療の用途別市場規模（病院、診療所、その他） ・遅発性ジスキネジア（TD）治療の北米市場規模2016-2027（アメリカ、カナダ） ・遅発性ジスキネジア（TD）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・遅発性ジスキネジア（TD）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・遅発性ジスキネジア（TD）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・遅発性ジスキネジア（TD）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Teva Pharma、Biogen、Johnson & Johnson、GlaxoSmithKline、Neurocrine Biosciences、Pfizer、Novartis、Sanofi、AstraZeneca、Bayer AG） ・結論

Tardive dyskinesia (TD) is a neurological disorder that has the involvement of the involuntary movements. The terms can be described as tardive which means delayed and dyskinesia which means abnormal movement. The symptoms of tardive dyskinesia include finger movement, facial grimacing, jaw swinging, repetitive chewing, continuous blinking of the eyes, tongue thrusting, and others. 

Market Analysis and Insights: Global Tardive Dyskinesia (TD) Treatment Market
The global Tardive Dyskinesia (TD) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tardive Dyskinesia (TD) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tardive Dyskinesia (TD) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tardive Dyskinesia (TD) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tardive Dyskinesia (TD) Treatment market.

Global Tardive Dyskinesia (TD) Treatment Scope and Market Size
Tardive Dyskinesia (TD) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tardive Dyskinesia (TD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Valbenazine
Amantadine
Tetrabenazine
Clonazepam
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva Pharma
Biogen
Johnson & Johnson
GlaxoSmithKline
Neurocrine Biosciences
Pfizer
Novartis
Sanofi
AstraZeneca

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tardive Dyskinesia (TD) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Valbenazine
1.2.3 Amantadine
1.2.4 Tetrabenazine
1.2.5 Clonazepam
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tardive Dyskinesia (TD) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tardive Dyskinesia (TD) Treatment Market Perspective (2016-2027)
2.2 Tardive Dyskinesia (TD) Treatment Growth Trends by Regions
2.2.1 Tardive Dyskinesia (TD) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tardive Dyskinesia (TD) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Tardive Dyskinesia (TD) Treatment Industry Dynamic
2.3.1 Tardive Dyskinesia (TD) Treatment Market Trends
2.3.2 Tardive Dyskinesia (TD) Treatment Market Drivers
2.3.3 Tardive Dyskinesia (TD) Treatment Market Challenges
2.3.4 Tardive Dyskinesia (TD) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tardive Dyskinesia (TD) Treatment Players by Revenue
3.1.1 Global Top Tardive Dyskinesia (TD) Treatment Players by Revenue (2016-2021)
3.1.2 Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Tardive Dyskinesia (TD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tardive Dyskinesia (TD) Treatment Revenue
3.4 Global Tardive Dyskinesia (TD) Treatment Market Concentration Ratio
3.4.1 Global Tardive Dyskinesia (TD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia (TD) Treatment Revenue in 2020
3.5 Tardive Dyskinesia (TD) Treatment Key Players Head office and Area Served
3.6 Key Players Tardive Dyskinesia (TD) Treatment Product Solution and Service
3.7 Date of Enter into Tardive Dyskinesia (TD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tardive Dyskinesia (TD) Treatment Breakdown Data by Type
4.1 Global Tardive Dyskinesia (TD) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Type (2022-2027)

5 Tardive Dyskinesia (TD) Treatment Breakdown Data by Application
5.1 Global Tardive Dyskinesia (TD) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tardive Dyskinesia (TD) Treatment Market Size (2016-2027)
6.2 North America Tardive Dyskinesia (TD) Treatment Market Size by Type
6.2.1 North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021)
6.2.2 North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027)
6.2.3 North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2027)
6.3 North America Tardive Dyskinesia (TD) Treatment Market Size by Application
6.3.1 North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021)
6.3.2 North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027)
6.3.3 North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2027)
6.4 North America Tardive Dyskinesia (TD) Treatment Market Size by Country
6.4.1 North America Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021)
6.4.2 North America Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Tardive Dyskinesia (TD) Treatment Market Size (2016-2027)
7.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Type
7.2.1 Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2027)
7.3 Europe Tardive Dyskinesia (TD) Treatment Market Size by Application
7.3.1 Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2027)
7.4 Europe Tardive Dyskinesia (TD) Treatment Market Size by Country
7.4.1 Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Type
8.2.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Application
8.3.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Region
8.4.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tardive Dyskinesia (TD) Treatment Market Size (2016-2027)
9.2 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type
9.2.1 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2027)
9.3 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application
9.3.1 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2027)
9.4 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country
9.4.1 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type
10.2.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application
10.3.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Country
10.4.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva Pharma
11.1.1 Teva Pharma Company Details
11.1.2 Teva Pharma Business Overview
11.1.3 Teva Pharma Tardive Dyskinesia (TD) Treatment Introduction
11.1.4 Teva Pharma Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.1.5 Teva Pharma Recent Development
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Tardive Dyskinesia (TD) Treatment Introduction
11.2.4 Biogen Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.2.5 Biogen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Tardive Dyskinesia (TD) Treatment Introduction
11.3.4 Johnson & Johnson Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Neurocrine Biosciences
11.5.1 Neurocrine Biosciences Company Details
11.5.2 Neurocrine Biosciences Business Overview
11.5.3 Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Introduction
11.5.4 Neurocrine Biosciences Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.5.5 Neurocrine Biosciences Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Tardive Dyskinesia (TD) Treatment Introduction
11.6.4 Pfizer Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Tardive Dyskinesia (TD) Treatment Introduction
11.7.4 Novartis Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Tardive Dyskinesia (TD) Treatment Introduction
11.8.4 Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Introduction
11.9.4 AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Tardive Dyskinesia (TD) Treatment Introduction
11.10.4 Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
11.10.5 Bayer AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Tardive Dyskinesia (TD) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Valbenazine
Table 3. Key Players of Amantadine
Table 4. Key Players of Tetrabenazine
Table 5. Key Players of Clonazepam
Table 6. Key Players of Others
Table 7. Global Tardive Dyskinesia (TD) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Tardive Dyskinesia (TD) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Tardive Dyskinesia (TD) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Tardive Dyskinesia (TD) Treatment Market Share by Regions (2016-2021)
Table 11. Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Tardive Dyskinesia (TD) Treatment Market Share by Regions (2022-2027)
Table 13. Tardive Dyskinesia (TD) Treatment Market Trends
Table 14. Tardive Dyskinesia (TD) Treatment Market Drivers
Table 15. Tardive Dyskinesia (TD) Treatment Market Challenges
Table 16. Tardive Dyskinesia (TD) Treatment Market Restraints
Table 17. Global Tardive Dyskinesia (TD) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Tardive Dyskinesia (TD) Treatment Market Share by Players (2016-2021)
Table 19. Global Top Tardive Dyskinesia (TD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tardive Dyskinesia (TD) Treatment as of 2020)
Table 20. Ranking of Global Top Tardive Dyskinesia (TD) Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Tardive Dyskinesia (TD) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Tardive Dyskinesia (TD) Treatment Product Solution and Service
Table 24. Date of Enter into Tardive Dyskinesia (TD) Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Tardive Dyskinesia (TD) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Teva Pharma Company Details
Table 65. Teva Pharma Business Overview
Table 66. Teva Pharma Tardive Dyskinesia (TD) Treatment Product
Table 67. Teva Pharma Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
Table 68. Teva Pharma Recent Development
Table 69. Biogen Company Details
Table 70. Biogen Business Overview
Table 71. Biogen Tardive Dyskinesia (TD) Treatment Product
Table 72. Biogen Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
Table 73. Biogen Recent Development
Table 74. Johnson & Johnson Company Details
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Tardive Dyskinesia (TD) Treatment Product
Table 77. Johnson & Johnson Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Product
Table 82. GlaxoSmithKline Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
Table 83. GlaxoSmithKline Recent Development
Table 84. Neurocrine Biosciences Company Details
Table 85. Neurocrine Biosciences Business Overview
Table 86. Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Product
Table 87. Neurocrine Biosciences Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
Table 88. Neurocrine Biosciences Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Tardive Dyskinesia (TD) Treatment Product
Table 92. Pfizer Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Tardive Dyskinesia (TD) Treatment Product
Table 97. Novartis Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
Table 98. Novartis Recent Development
Table 99. Sanofi Company Details
Table 100. Sanofi Business Overview
Table 101. Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
Table 102. Sanofi Recent Development
Table 103. AstraZeneca Company Details
Table 104. AstraZeneca Business Overview
Table 105. AstraZeneca Tardive Dyskinesia (TD) Treatment Product
Table 106. AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
Table 107. AstraZeneca Recent Development
Table 108. Bayer AG Company Details
Table 109. Bayer AG Business Overview
Table 110. Bayer AG Tardive Dyskinesia (TD) Treatment Product
Table 111. Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Business (2016-2021) & (US$ Million)
Table 112. Bayer AG Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tardive Dyskinesia (TD) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Valbenazine Features
Figure 3. Amantadine Features
Figure 4. Tetrabenazine Features
Figure 5. Clonazepam Features
Figure 6. Others Features
Figure 7. Global Tardive Dyskinesia (TD) Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Tardive Dyskinesia (TD) Treatment Report Years Considered
Figure 12. Global Tardive Dyskinesia (TD) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Tardive Dyskinesia (TD) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Tardive Dyskinesia (TD) Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Tardive Dyskinesia (TD) Treatment Market Share by Regions (2022-2027)
Figure 16. Global Tardive Dyskinesia (TD) Treatment Market Share by Players in 2020
Figure 17. Global Top Tardive Dyskinesia (TD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tardive Dyskinesia (TD) Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Tardive Dyskinesia (TD) Treatment Revenue in 2020
Figure 19. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Tardive Dyskinesia (TD) Treatment Market Share by Type (2016-2027)
Figure 23. North America Tardive Dyskinesia (TD) Treatment Market Share by Application (2016-2027)
Figure 24. North America Tardive Dyskinesia (TD) Treatment Market Share by Country (2016-2027)
Figure 25. United States Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Tardive Dyskinesia (TD) Treatment Market Share by Type (2016-2027)
Figure 29. Europe Tardive Dyskinesia (TD) Treatment Market Share by Application (2016-2027)
Figure 30. Europe Tardive Dyskinesia (TD) Treatment Market Share by Country (2016-2027)
Figure 31. Germany Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Tardive Dyskinesia (TD) Treatment Market Share by Region (2016-2027)
Figure 41. China Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Tardive Dyskinesia (TD) Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Tardive Dyskinesia (TD) Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Tardive Dyskinesia (TD) Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Tardive Dyskinesia (TD) Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Teva Pharma Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
Figure 61. Biogen Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
Figure 64. Neurocrine Biosciences Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
Figure 69. Bayer AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---